Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 1
---
 weighted average price of STAAR common stock on August 4, 2025 and an approximately 51% premium to the closing price of STAAR common stock on August 4, 2025, the last
trading day before the public announcement of the execution of the Merger Agreement. The common stock of STAAR is listed on NASDAQ under the symbol “STAA.” Following the consummation of the Merger, STAAR common stock will no longer be
listed on any stock exchange or quotation system, and STAAR will cease to be a publicly traded company.

The Merger cannot be completed without approval of the proposal to adopt the Merger Agreement by the affirmative vote of holders of a majority of the outstanding shares of STAAR common stock entitled to vote thereon. Because of this, STAAR is holding a special
meeting of its stockholders on October 23, 2025 to vote on the proposal necessary to consummate the Merger (the “Merger Proposal”). At the special meeting, stockholders will also be asked to vote on a proposal to approve, on an advisory
(nonbinding) basis, the compensation that may be paid or become payable to STAAR’s named executive officers that is based on or otherwise relates to the Merger Agreement and the transactions contemplated by the Merger Agreement (the
“Compensation Proposal”). Information about the meeting, the Merger, the Merger Agreement, and the other business to be considered by stockholders at the special meeting is contained in this proxy statement. The Board has fixed the close
of business on September 12, 2025 as the record date for the determination of STAAR stockholders entitled to notice of, and to vote at, the special meeting. Any stockholder entitled to attend and vote at the special meeting is entitled to appoint a
proxy to attend and vote on such stockholder’s behalf. Such proxy need not be a holder of STAAR common stock. We urge you to read this proxy statement (including the annexes hereto) and documents incorporated by reference
carefully.You should also carefully consider the risks that are described in the “Risk Factors” section beginning on page 23.

The Board has unanimously determined that the Merger Agreement and the transactions contemplated thereby, including the Merger, are advisable, fair to and in the best interests of STAAR and its stockholders, approved, adopted and declared advisable the execution and delivery of, and entry into, the Merger Agreement, and directed that the Merger Agreement be submitted